Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
Partnered Content
PDF Library
RSS Feeds
Subscribe
Advertising
Report Store
UsernamePublicRestriction
Tags:
BioPharmaceutical

PCMA Will Appeal Court Decision Upholding Maine’s PBM Transparency Law

This article was originally published in The Pink Sheet Daily

  • News

Executive Summary

Bangor, Maine federal court adopts magistrate judge’s recommendation that preliminary injunction against Maine law be overturned. PCMA is seeking to block the law based on federal preemption under ERISA and a violation of the Takings Clause of the U.S. Constitution.

You may also be interested in...



Maine PBM Transparency Law Upheld By Appeals Court

The ruling clears the way for the state to require certain disclosures from pharmacy benefit managers.

Maine PBM Transparency Law Upheld By Appeals Court

The ruling clears the way for the state to require certain disclosures from pharmacy benefit managers.

PCMA Launches Ad Campaign Targeting Independent Pharmacies

Print advertisements running in the Washington, D.C. area will stress that independent pharmacies are thriving and do not need special interest protections. The ad is drawn from a new PCMA study, which focuses on independent pharmacies and their legislative agenda.
Table

View full table

Related Content

Pink Sheet Pink Sheet Pink Sheet Pink Sheet

Topics

Tags:
BioPharmaceutical
UsernamePublicRestriction

Register

PS061983

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By